Grant Awarded to Enhance the Efficacy of Chemoradiation for Locally Advanced Esophageal Adenocarcinoma
Esophageal cancer, particularly esophageal adenocarcinoma, has been growing exponentially over the last five decades, especially in the United States.
- Esophageal cancer, particularly esophageal adenocarcinoma, has been growing exponentially over the last five decades, especially in the United States.
- Depending on results, this grant funding could increase up to $1 million.
- While chemo and radiation improve cure rates, they cause long-term side effects and half of all patients still die of their cancer.
- The goal of this research is to try to improve the treatment of esophageal adenocarcinoma using drugs which increase cure rates while also decreasing the side effects of chemo and radiation.